Abstract
As a large amount of blood loss is sometimes encountered in limb salvage procedures for pelvic tumours, it is essential to identify risk factors predicting the possibility of extensive haemorrhage. We retrospectively reviewed 137 patients who underwent pelvic tumour resections. Patients with an estimated blood loss greater than 3,000 ml were classified as having a large amount of blood loss. Sixty-one (44.53%) patients had blood loss greater than 3,000 ml. Tumours involving the acetabulum or sacrum, tumour volume greater than 400 cm3, aorta occlusion, resection method, reconstruction and operative time were all associated with a large amount of blood loss. Pelvic tumours involving the acetabulum or sacrum (odds ratio: 4.837), tumour volume greater than 400 cm3 (odds ratio: 3.005) and planned operation time of more than 200 min (odds ratio: 3.784) independently predicted a large amount of blood loss. Pelvic tumours with these characteristics were likely to have a large amount of blood loss during surgery.
Résumé
Très souvent, la perte sanguine est très importante dans le traitement des tumeurs pelviennes, il est donc essentiel d’identifier les facteurs de risques pouvant laisser penser qu’il y ait possibilité d’une hémorragie importante. Nous avons revu de façon rétrospective 137 patients présentant une tumeur du pelvis. Les patients qui avaient une perte sanguine estimée supérieure à 3 litres ont été classés comme patients présentant une perte sanguine importante. 61 (44,53%) ont eu une perte sanguine supérieure à 3 litres. Les tumeurs incluant le cotyle et le sacrum, les tumeurs dont le volume était supérieur à 400 cm3 avec des lésions au niveau de l’aorte nécessitant des gestes de résections et de reconstruction et un temps chirurgical important, tous ces facteurs sont associés à une importante perte sanguine. Dans les tumeurs incluant l’accétulum et le sacrum l’odds ratio est de 4,837, pour les tumeurs dont le volume est supérieur à 400 cm3, l’odds ratio est de 3,005, quand il est prévu une intervention dont le temps opératoire est supérieur à 200 minutes l’odds ratio 3,784. Les tumeurs pelviennes présentant toutes ces caractéristiques peuvent présenter de façon préférentielle d’importantes pertes sanguines durant la chirurgie.
Similar content being viewed by others
References
Abudu A, Grimer RJ, Cannon SR, Carter SR, Sneath RS (1997) Reconstruction of the hemipelvis after the excision of malignant tumours. Complications and functional outcome of prostheses. J Bone Joint Surg Br 79:773–779
Aljassir F, Beadel GP, Turcotte RE, Griffin AM, Bell RS, Wunder JS, Isler MH (2005) Outcome after pelvic sarcoma resection reconstructed with saddle prosthesis. Clin Orthop Relat Res 438:36–41
Apffelstaedt JP, Driscoll DL, Karakousis CP (1995) Partial and complete internal hemipelvectomy: complications and long-term follow-up. J Am Coll Surg 181(1):43–48
Beadel GP, McLaughlin CE, Aljassir F, Turcotte RE, Isler MH, Ferguson P, Griffin AM, Bell RS, Wunder JS (2005) Iliosacral resection for primary bone tumors: is pelvic reconstruction necessary? Clin Orthop Relat Res 438:22–29
Benevenia J, Cyran FP, Biermann JS, Patterson FR, Leeson MC (2004) Treatment of advanced metastatic lesions of the acetabulum using the saddle prosthesis. Clin Orthop Relat Res 426:23–31
Broaddus WC, Grady MS, Delashaw JB Jr, Ferguson RD, Jane JA (1990) Preoperative superselective arteriolar embolization: a new approach to enhance resectability of spinal tumors. Neurosurgery 27:755–759
Campanacci M, Capanna R (1991) Pelvic resections: the Rizzoli Institute experience. Orthop Clin North Am 22(1):65–86
Court C, Bosca L, Le Cesne AL, Nordin JY, Missenard G (2006) Surgical excision of bone sarcomas involving the sacroiliac joint. Clin Orthop Relat Res 451:189–194
Delloye C, Banse X, Brichard B, Docquier PL, Cornu O (2007) Pelvic reconstruction with a structural pelvic allograft after resection of a malignant bone tumor. J Bone Joint Surg Am 89(3):579–587
Devin C, Chong PY, Holt GE, Feurer I, Gonzalez A, Merchant N, Schwartz HS (2006) Level-adjusted perioperative risk of sacral amputations. J Surg Oncol 94:203–211
Enneking WF, Dunham WK (1978) Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am 60:731–746
Fuchs B, Yaszemski MJ, Sim FH (2002) Combined posterior pelvis and lumbar spine resection for sarcoma. Clin Orthop Relat Res 397:12–18
Guo W, Li D, Tang X, Yang Y, Ji T (2007) Reconstruction with modular hemipelvic prostheses for periacetabular tumor. Clin Orthop Relat Res 461:180–188
Keating EM (1998) Current options and approaches for blood management in orthopaedic surgery. J Bone Joint Surg Am 80:750–762
Kollender Y, Shabat S, Bickels J, Flusser G, Isakov J, Neuman Y, Cohen I, Weyl-Ben-Arush M, Ramo N, Meller I (2000) Internal hemipelvectomy for bone sarcomas in children and young adults: surgical considerations. Eur J Surg Oncol 26(4):398–404
Kunisada T, Choong PF (2000) Major reconstruction for periacetabular metastasis: early complications and outcome following surgical treatment in 40 hips. Acta Orthop Scand 71(6):585–590
Matsuda K, Nozawa M, Katsube S, Maezawa K, Kurosawa H (2008) Reinfusion of unwashed salvaged blood after total knee arthroplasty in patients with rheumatoid arthritis. Int Orthop. doi:10.1007/s00264-008-0661-5
Mi C, Lu H, Liu H (2005) Surgical excision of sacral tumors assisted by occluding the abdominal aorta with a balloon dilation catheter: a report of 3 cases. Spine 30:E614–E616
Ozaki T, Rödl R, Gosheger G, Hoffmann C, Poremba C, Winkelmann W, Lindner N (2003) Sacral infiltration in pelvic sarcomas: joint infiltration analysis II. Clin Orthop Relat Res 407:152–158
Pritchard DJ, Lunke RJ, Taylor WF, Dahlin DC, Medley BE (1980) Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer 45(1):149–157
Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ (2005) Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop Relat Res 435:211–218
Satcher Jr RL, O’Donnell RJ, Johnston JO (2003) Reconstruction of the pelvis after resection of tumors about the acetabulum. Clin Orthop Relat Res 409:209–217
Vena VE, Hsu J, Rosier RN, O’Keefe RJ (1999) Pelvic reconstruction for severe periacetabular metastatic disease. Clin Orthop Relat Res 362:171–180
Wirbel RJ, Schulte M, Mutschler WE (2001) Surgical treatment of pelvic sarcomas: oncologic and functional outcome. Clin Orthop Relat Res 390:190–205
Wurtz LD, Peabody TD, Simon MA (1999) Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. J Bone Joint Surg Am 81(3):317–325
Zeifang F, Buchner M, Zahlten-Hinguranage A, Bernd L, Sabo D (2004) Complications following operative treatment of primary malignant bone tumours in the pelvis. Eur J Surg Oncol 30(8):893–899
Contribution of authors
XT: main investigator, first and final draft. WG: conceived the study and reviewed the data analysis. RY, ST, TJ: co-investigators for data collection, first draft, and statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, X., Guo, W., Yang, R. et al. Evaluation of blood loss during limb salvage surgery for pelvic tumours. International Orthopaedics (SICOT) 33, 751–756 (2009). https://doi.org/10.1007/s00264-008-0695-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-008-0695-8